Chris Behrenbruch


Entrepreneur and Monash University alumnus Christian Behrenbruch (BEng (Hons) DPhil (Oxon) MBA (TRIUM) JD (Melb) FIEAust) is recognised internationally for commercialisation achievements in healthcare IT, medical device and biotechnology domains. He has particular expertise in university-industry technology transfer and has fostered entrepreneurship and commercialisation at universities internationally, and in Australia through his adjunct appointments at Monash University and RMIT University.

Dr Behrenbruch has over twenty years of healthcare entrepreneurship and executive leadership experience. He has previously served in a CEO or Executive Director capacity at Mirada Solutions, CTI Molecular Imaging (now Siemens Healthcare), Fibron Technologies and ImaginAb, Inc. He is a former Director of Momentum Biosciences LLC, Siemens Molecular Imaging Ltd, Radius Health Ltd (now Adaptix) and was the former Chairman of Cell Therapies Pty Ltd (a partnership with the Peter MacCallum Cancer Centre). Christian is currently a Director of Factor Therapeutics (ASX: FTT) and was previously a Director of Amplia Therapeutics Limited (ASX: ATX). Christian holds a DPhil (PhD) in biomedical engineering from the University of Oxford, an executive MBA jointly awarded from New York University, HEC Paris and the London School of Economics (TRIUM Program) and a Juris Doctor (Law) from the University of Melbourne. He is a Fellow of Engineers Australia in the management and biomedical colleges and a Graduate of the Australian Institute of Company Directors.

In 2011, he was recognisd by the World Economic Forum as an outstanding Young Global Leader, for his professional accomplishments, commitment to society and potential to contribute to shaping the future of the world.

Winner of the Advance Biotechnology Award 2012
> Meet 2012 award winner Christian Behrenbruch | Watch